An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

Galderma

Status: Completed

Conditions: Rosacea

Treatments: Drug: Metronidazole Gel

Study type: Observational

Funder types: Industry

Identifiers

NCT00668655

US10086

Details and patient eligibility

About

The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.

Full description

Evaluate the relationship between treatment with MetroGel® 1% and cosmetic performance with the Subjects' usual cosmetic products. It is expected that the female subjects will be able to use their routine cosmetics after application without affecting the cosmetic product's performance or causing side effects.

Enrollment: 30 patients

Sex: Female

Ages: 20 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with moderate Rosacea (Global Severity Score of 3),
• Subjects willing to stop their current rosacea medication for at least 2 weeks
• Subjects must have an established routine of cosmetics application (e.g. must have been using the same facial foundation for at least 3 months and it is not expected to change during the study)
• Subjects must be willing to use their routine facial foundation and not change products while on study

Exclusion criteria

• Subjects who do not routinely wear facial foundation
• Subjects who failed to undergo a washout period of 14 days for the use of topical rosacea therapy, (for example: metronidazole, azelaic acid, sulfacetamide)
• Subjects who are unwilling to stop their current rosacea medications for 2 weeks

Trial design

30 participants in 1 patient group

1

Description:

Female Subjects aged 20 to 75 inclusive, with a diagnosis of moderate (Global Severity Score of 3) Rosacea

Treatment:

Drug: Metronidazole Gel